Wednesday, August 7, 2024

Lykos Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for MDMA-Assisted Therapy for PTSD

›
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) ("Lykos"), a company dedicated to transforming mental healthcare, an...
Tuesday, August 6, 2024

Blood Test to Predict Schizophrenia Shows Promise

›
Researchers say they have developed a blood test for schizophrenia. More than 3 million people in the United States have schizophrenia, a di...
Monday, August 5, 2024

Liquidia Corporation Provides Update on New Drug Application for Yutrepia (treprostinil) inhalation powder

›
Liquidia Corporation (the Company) (NASDAQ: LQDA) announced  the U.S. Food and Drug Administration (FDA) providing  an update on its review ...
Friday, August 2, 2024

FDA Approves Eohilia (budesonide oral suspension) for the Treatment of Eosinophilic Esophagitis

›
 Takeda (TSE:4502/NYSE: TAK)   announced the U.S. Food and Drug Administration (FDA)   approval of Eohilia (budesonide oral suspension), the...
Thursday, August 1, 2024

FDA Approves Airsupra (albuterol/budesonide) Metered-Dose Inhaler to Reduce the Risk of Asthma Exacerbations

›
Airsupra (albuterol/budesonide), formerly known as PT027, has been approved in the US for the as-needed treatment or prevention of bronchoco...
Wednesday, July 31, 2024

Scientists Develop Sensor That Tests Saliva for Breast Cancer

›
Mammograms are a lifesaving misery for middle-aged women, but a new tool could make getting a breast cancer screening as easy as spitting. A...
Tuesday, July 30, 2024

Plant-Based Food Intake Linked to Better QoL in Prostate Cancer

›
Among patients with prostate cancer, greater consumption of plant-based foods is associated with higher scores in quality-of-life domains, a...
Monday, July 29, 2024

FDA Approves Zepbound (tirzepatide) for Chronic Weight Management

›
The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first an...
Friday, July 26, 2024

FDA Approves DefenCath (taurolidine and heparin) to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients

›
CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention ...
Thursday, July 25, 2024

FDA Approves Truqap (capivasertib) plus Faslodex for Patients with Advanced HR-Positive Breast Cancer

›
AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult patien...
Wednesday, July 24, 2024

FDA Approves Ogsiveo (nirogacestat) for Adults with Desmoid Tumors

›
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, anno...
Tuesday, July 23, 2024

FDA Approves Fabhalta (iptacopan) for the Treatment of Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

›
Novartis announced the U.S. Food and Drug Administration (FDA) approval of  Fabhalta ®  (iptacopan) as the first oral monotherapy for the tr...
Monday, July 22, 2024

FDA Approves iDose TR (travoprost intracameral implant) for the Treatment of Glaucoma

›
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment o...
Friday, July 19, 2024

FDA Approves Iwilfin (eflornithine) as Maintenance Therapy for High-Risk Neuroblastoma

›
USWM, LLC  announced the U.S. Food and Drug Administration (FDA)  approval of Iwilfin ™ (eflornithine) 192 mg tablets, a groundbreaking oral...
Thursday, July 18, 2024

FDA Approves Wainua (eplontersen) for the Treatment of Adults with Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

›
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced  the U.S. Food and Drug Administration (FDA)   approval of  Ionis and AstraZeneca's...